The "pRO" mise and "pRO" gress of PROs in cancer clinical trials

Amrita Basu, Dawn L. Hershman

Research output: Contribution to journal › Editorial › peer-review

Original languageEnglish
Pages (from-to)1544-1546
Number of pages3
JournalJournal of the National Cancer Institute
Volume116
Issue number10
DOIs
Publication statusPublished - Oct 1 2024

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  • SDG 3 - Good Health and Well-being

Access to Document

Other files and links

Cite this

Basu, A., & Hershman, D. L. (2024). The "pRO" mise and "pRO" gress of PROs in cancer clinical trials. Journal of the National Cancer Institute, 116(10), 1544-1546. https://doi.org/10.1093/jnci/djae157